Detected ·
Obsidian Therapeutics
——
Obsidian Therapeutics entered into a definitive merger agreement with Galera Therapeutics, alongside a concurrent $350 million oversubscribed private placement. The combined company will trade on Nasdaq under ticker OBX, with funding secured to advance OBX-115 through key clinical milestones into 2028.
- Website
- www.obsidiantx.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-20 03:03:11 UTC
- Signal ID
- c2a339f7-b8f9-4105-9c63-bd28655d3c54
As the API returns it
{
"id": "c2a339f7-b8f9-4105-9c63-bd28655d3c54",
"created_at": "2026-04-20T03:03:11.157841Z",
"company_name": "Obsidian Therapeutics",
"company_website_url": "www.obsidiantx.com",
"company_linkedin_url": "https://www.linkedin.com/company/obsidian-therapeutics",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Obsidian Therapeutics entered into a definitive merger agreement with Galera Therapeutics, alongside a concurrent $350 million oversubscribed private placement. The combined company will trade on Nasdaq under ticker OBX, with funding secured to advance OBX-115 through key clinical milestones into 2028.*"
}